The Biotechnology Group at RatnerPrestia includes professionals having advanced education, formal training, and extensive experience in diverse fields, from antibody applications and cellular biology to tissue engineering and virology. Group members are enabled to have a deep and quick understanding of innovations in the biotechnology areas, often in conjunction with other technology areas, for example, medical devices and pharmaceuticals, and to meet with our clients’ needs efficiently.
Our Biotechnology Team has extensive experience in all aspects of biotechnology patent practice, including prosecution, due diligence and opinions, and litigation. In particular, we have obtained and managed patent portfolios for our clients in the United States and other countries, and rendered opinions on patentability, patent validity, patent infringement, and freedom-to-operate. We have also advised our clients in various IP-related agreements, including technology transfer agreements, patent licensing agreement, and research collaboration agreements. Moreover, our Biotechnology Team members have conducted pre-filing investigations, and represented our clients in enforcing their patent rights as well as defending their freedom-to-operate in court.
RatnerPrestia has helped build or enhance the patent portfolios of a host of clients including universities, medical schools, pharmaceutical companies, all sizes of biotechnology companies, specialty and industrial chemical companies, and manufacturers of medical devices.